Page last updated: 2024-09-03

cgs 22652 and 6-ketoprostaglandin f1 alpha

cgs 22652 has been researched along with 6-ketoprostaglandin f1 alpha in 1 studies

Compound Research Comparison

Studies
(cgs 22652)
Trials
(cgs 22652)
Recent Studies (post-2010)
(cgs 22652)
Studies
(6-ketoprostaglandin f1 alpha)
Trials
(6-ketoprostaglandin f1 alpha)
Recent Studies (post-2010) (6-ketoprostaglandin f1 alpha)
10004,832294150

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cohen, DS; Dotson, R; Mathis, J; Olson, RW; Webb, RL1

Other Studies

1 other study(ies) available for cgs 22652 and 6-ketoprostaglandin f1 alpha

ArticleYear
Beneficial effects of combined thromboxane synthase inhibition/receptor blockade with CGS 22652 in a canine model of coronary thrombosis.
    European journal of pharmacology, 1993, May-12, Volume: 236, Issue:1

    Topics: 6-Ketoprostaglandin F1 alpha; Animals; Aspirin; Caprylates; Coronary Circulation; Coronary Thrombosis; Dinoprostone; Dogs; Hemodynamics; Indoles; Male; Myocardial Reperfusion; Phenylacetates; Platelet Activation; Platelet Aggregation Inhibitors; Pyridines; Receptors, Thromboxane; Streptokinase; Sulfonamides; Thromboxane B2; Thromboxane-A Synthase; Thromboxanes

1993